CTSO: Cytosorbents Corporation Stocks News on November 18, 2025

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

CTSO

PR Newswire

a day ago

Updated: CytoSorbents to Present at the Jefferies Global Healthcare Conference in London

CTSO

Zacks Small Cap Research

2 days ago

CTSO: CytoSorbents High Margin Revenue Growth Supports Price Target of $4.00

CTSO

GuruFocus.com

5 days ago

CytoSorbents Corp (CTSO) Q3 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ...

CTSO

Motley Fool

5 days ago

Cytosorbents (CTSO) Q3 2025 Earnings Transcript

CTSO

Associated Press Finance

5 days ago

CytoSorbents: Q3 Earnings Snapshot

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

CTSO

PR Newswire

5 days ago

CytoSorbents Reports Third Quarter 2025 Financial Results and Provides Business Update

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

CTSO

PR Newswire

7 days ago

CytoSorbents to Participate at the Jefferies Global Healthcare Conference in London

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

CTSO

PR Newswire

19 days ago

CytoSorbents to Report Third Quarter 2025 Financial Results and Recent Business Highlights

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

CTSO

PR Newswire

21 days ago

In Memoriam: Dr. Robert Hawes Bartlett (1939-2025) - Father of Extracorporeal Membrane Oxygenation (ECMO) and Former CytoSorbents Chief Medical Officer

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CTSO

PR Newswire

2 months ago

CytoSorbents To Host Global Webinar on "Turning the Tide in Sepsis and Septic Shock: Real World Insights with CytoSorb" in Recognition of World Sepsis Day

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

CTSO

PR Newswire

2 months ago

CytoSorbents to Present at the H.C. Wainwright 27th Annual Global Investment Conference

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

CTSO

PR Newswire

5 months ago

CytoSorbents Files Appeal with U.S. FDA for Supervisory Review of its De Novo Request for DrugSorb™-ATR

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

CTSO

PR Newswire

6 months ago

CytoSorbents to Participate at the Jefferies Global Healthcare Conference

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CTSO

PR Newswire

6 months ago

CytoSorbents Therapy Significantly Reduces Bleeding in Urgent CABG Patients on Ticagrelor in New Data Presented at EuroPCR 2025

CTSO

Zacks Small Cap Research

6 months ago

CTSO: CytoSorbents Reports Strong 1st Quarter 2025 Results

CTSO

Thomson Reuters StreetEvents

6 months ago

Q1 2025 Cytosorbents Corp Earnings Call

CTSO

GuruFocus.com

6 months ago

CytoSorbents Corp (CTSO) Q1 2025 Earnings Call Highlights: Navigating Challenges and ...

CTSO

Associated Press Finance

6 months ago

CytoSorbents: Q1 Earnings Snapshot

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CTSO

PR Newswire

6 months ago

CytoSorbents Reports First Quarter 2025 Financial Results and Provides Business Update

CTSO

GuruFocus.com

6 months ago

CytoSorbents Corp (CTSO) Q1 2025 Earnings Report Preview: What to Look For

CTSO

Zacks Small Cap Research

6 months ago

CTSO: CytoSorbents provides regulatory update for DrugSorb-ATR.

CTSO

PR Newswire

7 months ago

CytoSorbents Provides Regulatory Update for DrugSorb-ATR

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

CTSO

PR Newswire

7 months ago

CytoSorbents to Report First Quarter 2025 Financial Results and Recent Business Highlights

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

CTSO

PR Newswire

7 months ago

CytoSorbents Receives Approximately $1.7 Million from the New Jersey Business Tax Certificate Transfer Program

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CTSO

PR Newswire

7 months ago

CytoSorbents Appoints Melanie Grossman, CPA as Vice President and Corporate Controller

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

CTSO

PR Newswire

7 months ago

CytoSorbents Appoints Thomas Shannon as Vice President of Marketing for North America

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CTSO

PR Newswire

7 months ago

CytoSorbents Extends Expiration Date of Outstanding Series B Right Warrants

CTSO

Zacks Small Cap Research

7 months ago

CTSO: CytoSorbents Reports 4th quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

CTSO

Thomson Reuters StreetEvents

8 months ago

Q4 2024 Cytosorbents Corp Earnings Call

CTSO

GuruFocus.com

8 months ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...

CTSO

Associated Press Finance

8 months ago

CytoSorbents: Q4 Earnings Snapshot

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CTSO

PR Newswire

8 months ago

CytoSorbents Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CTSO

GuruFocus.com

8 months ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What to Look For

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

CTSO

PR Newswire

8 months ago

CytoSorbents Reschedules Earnings Release to March 31, 2025 to Allow Additional Time to Complete Annual Audit

CTSO

Simply Wall St.

8 months ago

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 78% loss from investing in the stock five years ago

CTSO

GuruFocus.com

8 months ago

CytoSorbents Corp (CTSO) Q4 2024 Earnings Report Preview: What To Expect

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CTSO

GlobeNewswire

9 months ago

CytoSorbents Postpones Earnings Release to Allow More Time to Complete Annual Audit Following the Passing of Corporate Controller

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CTSO

GlobeNewswire

9 months ago

CytoSorbents to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

CTSO

GlobeNewswire

9 months ago

CytoSorbents Further Strengthens Balance Sheet with Exercise of Previously Announced Series A Right Warrants

Cytosorbents Boosts Liquidity with Successful Rights Offering

CTSO

TipRanks

10 months ago

Cytosorbents Boosts Liquidity with Successful Rights Offering

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

CTSO

GlobeNewswire

10 months ago

CytoSorbents Strengthens Balance Sheet with Closing of Oversubscribed Rights Offering

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

CTSO

GlobeNewswire

10 months ago

CytoSorbents Expands Global Footprint with Opening of New Regional Sales Subsidiary in Dubai

CytoSorbents reported strong Q4 results, says D. Boral Capital

CTSO

TipRanks

10 months ago

CytoSorbents reported strong Q4 results, says D. Boral Capital

CTSO

Zacks Small Cap Research

10 months ago

CTSO: CytoSorbents Reports Preliminary 4th Quarter and 2024 Financial Results Which Showed Impressive Product Revenue Growth That Exceeded Our Expectations.

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

CTSO

GlobeNewswire

10 months ago

CytoSorbents Reports Preliminary Unaudited Fourth Quarter and Full-Year 2024 Product Revenue

CTSO

GlobeNewswire

a year ago

CytoSorbents Rights Offering Begins

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

CTSO

GlobeNewswire

a year ago

CytoSorbents to Host Investor Meetings in San Francisco During J.P. Morgan Healthcare Conference Week

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Announces Rights Offering Which has the Potential to Substantially Increase Available Liquidity

CTSO

GlobeNewswire

a year ago

CytoSorbents Announces Rights Offering

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

CTSO

GlobeNewswire

a year ago

CytoSorbents to Participate at the Piper Sandler 36th Annual Healthcare Conference

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

Several Insiders Invested In Cytosorbents Flagging Positive News

CTSO

Simply Wall St.

a year ago

Several Insiders Invested In Cytosorbents Flagging Positive News

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

CTSO

GlobeNewswire

a year ago

CytoSorbents And Converge Biotech Announce Strategic Partnership to Expand Sepsis and Critical Care Treatment with CytoSorb in India

CTSO

GuruFocus.com

a year ago

CytoSorbents Corp (CTSO) Q3 2024 Earnings Call Highlights: Strong Sales Growth and Improved ...

CTSO

Associated Press Finance

a year ago

CytoSorbents: Q3 Earnings Snapshot

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

CTSO

GlobeNewswire

a year ago

CytoSorbents Reports Third Quarter 2024 Financial and Operational Results

CTSO

GuruFocus.com

a year ago

CytoSorbents Corp (CTSO) Q3 2024: Everything You Need to Know Ahead of Earnings

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

CTSO

GlobeNewswire

a year ago

CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

CTSO

GlobeNewswire

a year ago

FDA Accepts DrugSorb-ATR De Novo Application To Reduce the Severity of CABG-Related Bleeding Due to Ticagrelor and Initiates Substantive Review

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

CTSO

GlobeNewswire

a year ago

CytoSorbents to Report Third Quarter 2024 Operating and Financial Results

CTSO

GuruFocus.com

a year ago

CytoSorbents Corp (CTSO) Q2 2024 Earnings Call Highlights: Revenue Growth and Strategic ...

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Announces Submission of DrugSorb-ATR Application to the FDA

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

CTSO

GlobeNewswire

a year ago

CytoSorbents Submits DrugSorb-ATR Marketing Application to U.S. FDA to Reduce the Severity of Bleeding in Heart Bypass Surgery Patients on the Blood Thinner Ticagrelor and Provides Business Update

CTSO

Simply Wall St.

a year ago

Cytosorbents (NASDAQ:CTSO) shareholders have endured a 81% loss from investing in the stock three years ago

CTSO

Zacks Small Cap Research

a year ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

CTSO

GlobeNewswire

a year ago

CytoSorbents to Present at the H.C. Wainwright 26ᵗʰ Annual Global Investment Conference

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CTSO

GlobeNewswire

a year ago

CytoSorbents Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

CTSO

Associated Press Finance

a year ago

CytoSorbents: Q2 Earnings Snapshot

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

CTSO

GlobeNewswire

a year ago

CytoSorbents Reports Second Quarter 2024 Financial and Operational Results

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

CTSO

GlobeNewswire

a year ago

CytoSorbents Appoints Peter J. Mariani Chief Financial Officer

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

CTSO

GlobeNewswire

a year ago

CytoSorbents to Report Second Quarter 2024 Operating and Financial Results

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

CTSO

GlobeNewswire

a year ago

CytoSorbents Announces Compliance with Nasdaq Minimum Bid Price Requirement

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CTSO

GlobeNewswire

a year ago

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CTSO

GlobeNewswire

a year ago

CytoSorbents Unveils Newly Redesigned, Unified Company and Product Website

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

CTSO

GlobeNewswire

a year ago

CytoSorbents to Present at the Inaugural American Association of Physicians of Indian Origin (AAPI) World Health Congress

CytoSorbents Secures $20 Million Credit Facility

CTSO

GlobeNewswire

a year ago

CytoSorbents Secures $20 Million Credit Facility

CTSO

MT Newswires

a year ago

CytoSorbents' Blood Purification Device Gets Approval in Taiwan

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

CTSO

GlobeNewswire

a year ago

CytoSorbents Announces Regulatory Approval of CytoSorb® in Taiwan

CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union

CTSO

GlobeNewswire

a year ago

CytoSorbents Announces the Launch and Immediate Availability of the PuriFi™ Blood Pump in the European Union

Edge Total Intelligence Inc. Updates Status of MCTO

CTSO

Newsfile

a year ago

Edge Total Intelligence Inc. Updates Status of MCTO

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

CTSO

CNW Group

a year ago

HEATHERWICK STUDIO UNVEILS ICONIC GLASS CANOPY, THE JEWEL IN THE CROWN OF REIMAGINED OLYMPIA

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

CTSO

GlobeNewswire

a year ago

The sale of Aspo's subsidiary ESL Shipping's Supramax vessels has been completed on June 11 2024

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

CTSO

GlobeNewswire

a year ago

Nokia introduces Network Exposure Platform to expand and simplify network API exposure for service providers

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

CTSO

GlobeNewswire

a year ago

LED Driver with CAN Bus for Dynamic Automotive Interior RGB Lighting

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

CTSO

GlobeNewswire

a year ago

Hofseth Biocare ASA: AGREES CHINA DISTRIBUTION PARTNERSHIP WITH SHANGHAI-BASED LITHY

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CTSO

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

CTSO

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

CTSO

GlobeNewswire

a year ago

CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

CTSO

GlobeNewswire

a year ago

CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract

CTSO

Simply Wall St.

a year ago

Here's Why Shareholders Should Examine Cytosorbents Corporation's (NASDAQ:CTSO) CEO Compensation Package More Closely

CTSO

Zacks Small Cap Research

2 years ago

CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00

Cytosorbents First Quarter 2024 Earnings: In Line With Expectations

CTSO

Simply Wall St.

2 years ago

Cytosorbents First Quarter 2024 Earnings: In Line With Expectations

CTSO

Insider Monkey

2 years ago

Cytosorbents Corporation (NASDAQ:CTSO) Q1 2024 Earnings Call Transcript

CTSO

Associated Press Finance

2 years ago

CytoSorbents: Q1 Earnings Snapshot

CytoSorbents Reports First Quarter 2024 Results

CTSO

GlobeNewswire

2 years ago

CytoSorbents Reports First Quarter 2024 Results

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

CTSO

GlobeNewswire

2 years ago

CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results & Real World Experience with Antithrombotic Drug Removal in Europe

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

CTSO

GlobeNewswire

2 years ago

CytoSorbents to Report First Quarter 2024 Operating and Financial Results

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

CTSO

GlobeNewswire

2 years ago

STAR-T Pivotal Trial Results to Be Featured as a Late-Breaking Presentation at the 2024 American Association for Thoracic Surgery Annual Meeting

CTSO

Zacks Small Cap Research

2 years ago

CTSO: CytoSorbents Expects Significant Gross Margin Expansion in 2023.

CTSO

Simply Wall St.

2 years ago

Latest Cytosorbents Corporation (CTSO) News on November 18, 2025

Share on Social Networks: